C M LIFE VARIABLE LIFE SEPARATE ACCOUNT I
497, 1995-11-22
Previous: OPPENHEIMER INTERNATIONAL BOND FUND, NSAR-BT, 1995-11-22
Next: PILGRIM AMERICA MASTERS SERIES INC, 497, 1995-11-22




                       SUPPLEMENT DATED NOVEMBER 22, 1995
                                      TO
                       PROSPECTUS DATED AUGUST 28, 1995
                  C.M. LIFE VARIABLE LIFE SEPARATE ACCOUNT I
                  EXECUTIVE BENEFIT VARIABLE UNIVERSAL LIFE

    On or about December 1, 1995, C.M. Life Insurance Company ("C.M. Life") and
several other applicants intend to file an application with the Securities and
Exchange Commission seeking an order approving the substitution of shares
issued by Oppenheimer Variable Accounts Funds ("OVAF") for shares of certain
investment portfolios of Connecticut Mutual Financial Services Series Fund I,
Inc. ("CMFSSF") currently held by various Sub-Accounts of C.M. Life Variable
Life Separate Account I ("Account I").  To the extent required by law,
approvals of such substitutions will also be obtained from the state insurance
regulators in certain jurisdictions.  The effect of such a share substitution
would be to replace the portfolios of CMFSSF with those of OVAF as investment
options under the Executive Benefit Variable Universal Life insurance policies
described in your August 28, 1995 prospectus.

     More particularly, C.M. Life proposes to substitute:  (1) shares issued
by OVAF representing interests in OVAF'S Money Fund for shares currently held
in a Sub-Account of Account I representing interests in CMFSSF's Money Market
Portfolio, (2) shares issued by OVAF representing interests in OVAF'S Bond
Fund for shares currently held in a Sub-Account of Account I representing
interests in CMFSSF's Income Portfolio, and (3) shares issued by OVAF 
representing interests in OVAF's Bond Fund for shares currently held in a 
Sub-Account of Account I representing interests in CMFSSF's Government
Securities Portfolio.  If approved by the SEC and appropriate state insurance 
regulators, C.M. Life would carry out the proposed substitutions by redeeming
the CMFSSF shares described above and purchasing with the proceeds, OVAF shares
as described above.  If carried out, the proposed substitutions would result in
the involuntary reinvestment of policyowners' Policy Values, if any, invested 
in the foregoing CMFSSF Portfolios in the OVAF Funds as outlined above.

     The investment objectives of the OVAF Money Fund and Bond Fund are
summarized below.  Policyowners and prospective purchasers should carefully
read the prospectus for the OVAF Money Fund and Bond Fund.  C.M. Life will
send each policyowner a copy of this prospectus before the proposed 
substitutions are carried out.

    OVAF Money Fund seeks the maximum current income from investments in "money
    market" securities consistent with low capital risk and maintenance of
    liquidity.

    OVAF Bond Fund seeks a high level of current income from investments in
    high-yield, fixed income securities rated "Baa" or better by Moody's or 
    "BBB" or better by Standard & Poor's.  As a secondary objective, the Bond 
    Fund seeks capital growth when consistent with its primary objective.

     From the date of this supplement to the date of the proposed
substitutions, each policyowner will be permitted to make one transfer of all
of his or her Policy Value in any of the Sub-Accounts of Account I that would
be affected by the proposed substitutions without that transfer counting as
one of the 12 free transfers permitted in a Policy Year.  In addition, the
competing option restriction will not apply to this transfer.  Furthermore,
from the date of this supplement until 30 days after the proposed substitution,
C.M. Life will not impose any further restrictions on transfers among and
between the Sub-Accounts of Account I or the Fixed Account.

     If the proposed substitutions are carried out, each policyowner affected 
by the substitutions will be permitted, within 30 days from the date of the 
substitution, to make one transfer of all of his or her Policy Value in any of 
the Sub-Accounts of Account I that were affected by the proposed substitutions 
without that transfer counting as one of the 12 free transfers permitted in a 
Policy Year.  In addition, the competing option restriction will not apply to 
this one transfer.

     The proposed substitutions have come about as an indirect result of an
Agreement and Plan of Merger between Connecticut Mutual Life Insurance Company
(which owns C.M. Life) and Massachusetts Mutual Life Insurance Company,
pursuant to which Connecticut Mutual would merge with and into Massachusetts
Mutual.  Upon consummation of the Merger, the separate existence of
Connecticut Mutual would cease and Massachusetts Mutual would continue its
corporate existence under its current name.  It is currently anticipated that
this Merger would occur during the first three months of 1996.  If the
approvals described above are obtained, C.M. Life currently intends to carry
out the proposed substitutions within several months of the Merger of
Connecticut Mutual with and into Massachusetts Mutual.  If the Merger does not
occur, C.M. Life will not carry out the proposed substitutions.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission